If you or a relative have been diagnosed with Mesothelioma, the likely cause is exposure to asbestos fibers. Today attorneys are bringing legal action against asbestos makers and successor companies. Lawyers have shown that these companies were negligent because they knew that asbestos was a carcinogen fro decades. The companies for years downplayed the risks, which were long-term and did not take action to protect their workers or warn them of the hazards in the long run.. Today, people with mesothelioma have the right to recover against asbestos makers, helping to defray the costs of treatment and provide compensation for your pain and suffering.
An attorney will have to look at the following factors to make your claim:
1) Statute of Limitations
2) Identify Your Exposure
3) Responsible Parties
1) Statute of Limitations
Your first concern is to file within the statutory deadlines. If you have been diagnosed with Mesothelioma, you must file within a few years.
If you are the executor of the estate of a person who has died from asbestos-related disease, you may be eligible to file a claim but the claim must be within a short time of the death. A family member exposed in a secondary manner (for example, through asbestos fibers brought home on clothes by a parent who worked in an asbestos environment) may also be eligible to file a claim.
Because of the statute of limitation issues, you should contact our specialists as soon as possible regarding your eligibility.
2) Identify the Exposure
If you have Mesothelioma, that alone is not grounds for a lawsuit. In order to establish a claim (against manufacturers, distributors, and/or contractors) it must be established that you had been exposed to the specific asbestos product at a specific location. If you do not remember the name of the manufacturer of the particular asbestos product that was used on your job site (that caused your asbestos-related disease), our experts can find out for you.
3) Responsible Parties
If you have found where you where you were exposed to asbestos, our researchers will find the responsible parties who are capable of paying. For you to file a claim, our attorneys must be able to locate a company that is ultimately responsible and still in business in some form or another.
What will your compensation be for the damages?
As mentioned above, we will help you locate information about responsible parties for your asbestos exposure. Your compensation will be determined by factors such as lost income, the laws in your state, and the parties responsible. Compensation for Mesothelioma can vary from several thousand to several million. Getting the highest possible compensation for your damages requires tough and experienced attorneys. Our mission is to match your case with those capable attorneys.
You may contact us here if you have been diagnosed with malignant mesothelioma as a result of connection with an occupation.
Wednesday, March 25, 2009
Mesothelioma Clinical Trials
Clinical trials are studies of new treatments in patients. Researchers perform a clinical trial only when there is some reason to believe that the treatment in question may help patients. In general researchers perform clinical trials to determine whether a treatment works, whether it is more effective then existing treatments, whether the side effects are too severe to justify the treatments use, and which patients benefit most from the treatment. Currently, there are sixteen active clinical trials throughout the world investigating new therapies for mesothelioma. Researchers are conducting eleven of those trials in the United States.
During the course of treatment, a doctor may suggest that a patient look into a clinical trial. Though this does not mean that the patient has no other hope, the patient should be aware of the risks associated with clinical trials. No one knows in advance if the treatment will work or exactly what side effects will occur.
Researchers conduct clinical trials in steps called phases. Each phase answers certain questions. Clinical trials are usually classified into one of three phases.
Phase I trials evaluate how doctors should administer a new drug (i.e. by mouth, injected into the blood, or injected into the muscle), how often, and at what dose. A Phase I trial usually enrolls only a small number of patients, sometimes as few as a dozen.
Phase II trials continue to test the safety of the drug, and begin to evaluate how well the new drug works. Phase II studies usually narrow the focus to a particular type of cancer.
Phase III trials test a new drug, a new combination of drugs, or a new surgical procedure in comparison to the current standard. Researchers assign participants to the standard group or the new group at random. Phase III trials often enroll large numbers of people and may be conducted at many doctors' offices, clinics, and cancer centers nationwide.
The benefit of participating in a clinical trial is that a patient can receive a treatment that the U.S. Food and Drug Administration has yet to approve. In the case of promising drugs, this may improve the patient chance of survival.
During the course of treatment, a doctor may suggest that a patient look into a clinical trial. Though this does not mean that the patient has no other hope, the patient should be aware of the risks associated with clinical trials. No one knows in advance if the treatment will work or exactly what side effects will occur.
Researchers conduct clinical trials in steps called phases. Each phase answers certain questions. Clinical trials are usually classified into one of three phases.
Phase I trials evaluate how doctors should administer a new drug (i.e. by mouth, injected into the blood, or injected into the muscle), how often, and at what dose. A Phase I trial usually enrolls only a small number of patients, sometimes as few as a dozen.
Phase II trials continue to test the safety of the drug, and begin to evaluate how well the new drug works. Phase II studies usually narrow the focus to a particular type of cancer.
Phase III trials test a new drug, a new combination of drugs, or a new surgical procedure in comparison to the current standard. Researchers assign participants to the standard group or the new group at random. Phase III trials often enroll large numbers of people and may be conducted at many doctors' offices, clinics, and cancer centers nationwide.
The benefit of participating in a clinical trial is that a patient can receive a treatment that the U.S. Food and Drug Administration has yet to approve. In the case of promising drugs, this may improve the patient chance of survival.
Subscribe to:
Comments (Atom)